Skip to content

PHARMACIE LADURON

Active
Private limited companyfounded 1986active for 39 yearsRue Feron 2, 4530 Villers-le-Bouillet, BelgiumKBO/BCE: BE 0429.916.074
Summary

PHARMACIE LADURON has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €269,589 and a net result of €169,484. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 90% of 22,581 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
PHARMACIE LADURONActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
5th oldest company in Villers-le-Bouillet, Wholesale and retail trade sector1 site
Size
€325,500total assets 2025
Equity
€269,589
Profit
€169,484
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 64 days early2 deeds in the Belgian Official Gazette
Why 98raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1986Liquidity: current ratio 5.60, cash €41,384Equity €269,589 (82.8% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 87% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 82.8% of total assets
Liquidity 62-30
short-term debt 17.0% · cash 12.7%
Profitability 100+17
return on assets 52.1%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 5.6, compared with 7.62 in 2024, above the usual 1.5; short-term debt: 17% and cash: 12.7% of total assets), and 17.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 68% on liquidity, 96% on profitability and 93% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1986
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Liquidity: current ratio 5.60, cash €41,384
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €269,589 (82.8% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
64 days early
2024
65 days early
2023
57 days early
2022
47 days early
2021
53 days early
2020
26 days early
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 45 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2018 to 2025net €169,484 ▲981%
  3. Equity above €200,000equity €269,589 ▲107%

Key points

  • Positive: Result rose in 2025from €15,680 to €169,484 ▲ 981% View
  • Positive: Among the best 5% on net resultsector median €5,083 · 22,562 companies €169,484 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €169,484 8 years View

By topic

Financials

Financial year
2025
Total assets
€325,500
Profit
€169,484
Solvency
82.8%
Total assets▲ 128%
Net result
20182025
Go to Financials

Timeline

Events
45
Since
1988
Next accounts
by 31-07-2027
  1. 27-05-2025Annual accounts filed
  2. 04-06-2024Annual accounts filed
  3. 31-12-2023Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
01-12-1986
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about PHARMACIE LADURON

What is the company number of PHARMACIE LADURON?
0429.916.074. In Belgium the VAT number is the company number with BE in front: BE 0429.916.074.
Where is PHARMACIE LADURON based?
The registered office is at Rue Feron 2, 4530 Villers-le-Bouillet.Company details
What does PHARMACIE LADURON do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE LADURON?
Private limited company (BV).
When was PHARMACIE LADURON founded?
On 01-12-1986.
Is PHARMACIE LADURON still active?
Yes, PHARMACIE LADURON is an active enterprise in the KBO register.
What is the turnover of PHARMACIE LADURON?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is PHARMACIE LADURON profitable?
In financial year 2025, PHARMACIE LADURON made a profit of €169,484.
Where can I find the annual accounts of PHARMACIE LADURON?
PHARMACIE LADURON filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE LADURON due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to PHARMACIE LADURON

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure